Metabolite profiling of fecal water extracts from human colorectal cancer
- PMID: 19006102
- DOI: 10.1002/nbm.1345
Metabolite profiling of fecal water extracts from human colorectal cancer
Abstract
Colorectal cancer is the second leading cause of cancer death in developed countries. There is a need for better preventive strategies to improve the outcome of this disease. The increasing availability of high-throughput methodologies opens up new possibilities for screening new markers. The application of NMR metabolic profiling to fecal water extracts has interesting potential as a diagnostic tool for detecting colorectal cancer. We obtained NMR metabolic profiles of fecal water extracts from patients with colorectal cancer and healthy individuals, to characterize possible differences between them and to identify potential diagnostic markers. Our results show that metabolic profiling of fecal water extracts is a cheap, reproducible and effective method for detecting colorectal cancer markers and therefore complements other stool-screening methods. A low concentration of short-chain fatty acids, such as acetate and butyrate, previously associated with the development of colorectal cancer, appears to be the most effective marker. Concentrations of proline and cysteine, which are major components of most colonic epithelium mucus glycoproteins, also display significant changes in samples from colorectal cancer. Differentiation between fecal water extracts from controls and patients with colorectal cancer by NMR spectroscopy combined with chemometric techniques opens up new possibilities for developing new, efficient, high-throughput screening protocols.
Similar articles
-
Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts.NMR Biomed. 2009 Jul;22(6):593-600. doi: 10.1002/nbm.1372. NMR Biomed. 2009. PMID: 19259992
-
Evaluation of calgranulin B in stools from the patients with colorectal cancer.Dis Colon Rectum. 2008 Nov;51(11):1703-9. doi: 10.1007/s10350-008-9381-6. Epub 2008 Jun 27. Dis Colon Rectum. 2008. PMID: 18584251 Clinical Trial.
-
(1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome.NMR Biomed. 2008 Jul;21(6):615-26. doi: 10.1002/nbm.1233. NMR Biomed. 2008. PMID: 18085514 Clinical Trial.
-
MR metabolomics of fecal extracts: applications in the study of bowel diseases.Magn Reson Chem. 2009 Dec;47 Suppl 1:S54-61. doi: 10.1002/mrc.2530. Magn Reson Chem. 2009. PMID: 19842159 Review.
-
Stool test for colorectal cancer screening--it's time to move!Clin Lab. 2008;54(11-12):473-84. Clin Lab. 2008. PMID: 19216253 Review.
Cited by
-
Determination of urinary 5-hydroxyindoleacetic acid as a metabolomics in gastric cancer.J Gastrointest Cancer. 2015 Jun;46(2):138-42. doi: 10.1007/s12029-015-9700-9. J Gastrointest Cancer. 2015. PMID: 25761643
-
Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.Gut Microbes. 2016 Sep 2;7(5):397-413. doi: 10.1080/19490976.2016.1215805. Epub 2016 Jul 26. Gut Microbes. 2016. PMID: 27662586 Free PMC article.
-
Short-chain fatty acid concentrations in the incidence and risk-stratification of colorectal cancer: a systematic review and meta-analysis.BMC Med. 2022 Oct 3;20(1):323. doi: 10.1186/s12916-022-02529-4. BMC Med. 2022. PMID: 36184594 Free PMC article.
-
Increased sporulation underpins adaptation of Clostridium difficile strain 630 to a biologically-relevant faecal environment, with implications for pathogenicity.Sci Rep. 2018 Nov 12;8(1):16691. doi: 10.1038/s41598-018-35050-x. Sci Rep. 2018. PMID: 30420658 Free PMC article.
-
Nuclear Magnetic Resonance technique in tumor metabolism.Genes Dis. 2016 Dec 13;4(1):28-36. doi: 10.1016/j.gendis.2016.12.001. eCollection 2017 Mar. Genes Dis. 2016. PMID: 30258906 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical